ATE333445T1 - Pyrazolderivate - Google Patents

Pyrazolderivate

Info

Publication number
ATE333445T1
ATE333445T1 AT01945553T AT01945553T ATE333445T1 AT E333445 T1 ATE333445 T1 AT E333445T1 AT 01945553 T AT01945553 T AT 01945553T AT 01945553 T AT01945553 T AT 01945553T AT E333445 T1 ATE333445 T1 AT E333445T1
Authority
AT
Austria
Prior art keywords
pyrazole derivatives
pyrazole
derivatives
Prior art date
Application number
AT01945553T
Other languages
English (en)
Inventor
Romuald Gaston Corbau
Charles Eric Mowbray
Manoussos Perros
Paul Anthony Stupple
Anthony Wood
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of ATE333445T1 publication Critical patent/ATE333445T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A61K31/4155—1,2-Diazoles non condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/433—Thidiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A61K31/501—Pyridazines; Hydrogenated pyridazines not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/18—One oxygen or sulfur atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/18—One oxygen or sulfur atom
    • C07D231/20—One oxygen atom attached in position 3 or 5
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/38—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • AIDS & HIV (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT01945553T 2000-07-07 2001-06-21 Pyrazolderivate ATE333445T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0016787.4A GB0016787D0 (en) 2000-07-07 2000-07-07 Compounds useful in therapy

Publications (1)

Publication Number Publication Date
ATE333445T1 true ATE333445T1 (de) 2006-08-15

Family

ID=9895273

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01945553T ATE333445T1 (de) 2000-07-07 2001-06-21 Pyrazolderivate

Country Status (21)

Country Link
US (2) US6750230B2 (de)
EP (1) EP1299361B1 (de)
JP (1) JP2004502760A (de)
AP (1) AP2001002204A0 (de)
AT (1) ATE333445T1 (de)
AU (1) AU2001267766A1 (de)
BR (1) BR0112252A (de)
CA (1) CA2415492A1 (de)
DE (1) DE60121590T2 (de)
ES (1) ES2266212T3 (de)
GB (1) GB0016787D0 (de)
GT (1) GT200100132A (de)
HN (1) HN2001000146A (de)
MX (1) MXPA03000059A (de)
PA (1) PA8521701A1 (de)
PE (1) PE20020131A1 (de)
PY (1) PY0116238A (de)
SV (1) SV2002000520A (de)
TN (1) TNSN01102A1 (de)
UY (1) UY26819A1 (de)
WO (1) WO2002004424A1 (de)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6455559B1 (en) 2001-07-19 2002-09-24 Pharmacia Italia S.P.A. Phenylacetamido-pyrazole derivatives, process for their preparation and their use as antitumor agents
SI1762567T1 (sl) 2001-04-10 2012-08-31 Pfizer Derivati pirazola za zdravljenje HIV-a
GB0113524D0 (en) * 2001-06-04 2001-07-25 Hoffmann La Roche Pyrazole derivatives
AU2002360818A1 (en) * 2001-12-28 2003-07-24 Bayer Pharmaceuticals Corporation 1h-pyrazolyl derivative compounds, for use in diseases associated with the 5-ht2c receptor
ATE302203T1 (de) 2002-03-07 2005-09-15 Smithkline Beecham Corp Pyrazolopyrimidin- und pyrazolotriazinderivate und diese enthaltende pharmazeutische zubereitungen
UA79804C2 (en) * 2002-07-03 2007-07-25 Janssen Pharmaceutica Nv Cck-1 receptor modulators
US20040132793A1 (en) * 2002-09-16 2004-07-08 Pfizer Inc. Pyrazole derivatives
GB0221477D0 (en) * 2002-09-16 2002-10-23 Pfizer Ltd Chemical compounds
US7230025B2 (en) 2002-09-26 2007-06-12 Pfizer, Inc. Pyrazole derivatives
MXPA05002004A (es) * 2002-09-26 2005-04-28 Pfizer Derivados de pirazol.
GB0223232D0 (en) * 2002-10-07 2002-11-13 Pfizer Ltd Chemical compounds
GB0223234D0 (en) * 2002-10-07 2002-11-13 Pfizer Ltd Chemical compounds
US6933312B2 (en) 2002-10-07 2005-08-23 Agouron Pharmaceuticals, Inc. Pyrazole derivatives
RU2332412C2 (ru) 2003-02-07 2008-08-27 Дайити Фармасьютикал Ко., Лтд. Производные пиразола
TW200423930A (en) * 2003-02-18 2004-11-16 Hoffmann La Roche Non-nucleoside reverse transcriptase inhibitors
ATE410161T1 (de) * 2003-05-02 2008-10-15 Elan Pharm Inc 4-bromo-5-(2-chloro-benzoylamino)-1h-pyrazol-3- carbonsäureamid-derivate und verwandte verbindungen als bradykinin b1 rezeptor antagonisten zur behandlung von entzündlichen erkrankungen
US7220772B2 (en) 2003-09-05 2007-05-22 Pfizer, Inc. Pyrazole derivatives
EP1740550A1 (de) * 2004-04-14 2007-01-10 Pfizer Limited Schwefelgebundene imidazolverbindungen zur behandlung von hiv
WO2005118543A1 (ja) * 2004-06-03 2005-12-15 Ono Pharmaceutical Co., Ltd. キナーゼ阻害薬およびその用途
US7531560B2 (en) * 2004-11-10 2009-05-12 Boehringer Ingelheim Pharmaceuticals, Inc. Anti-cytokine heterocyclic compounds
CA2592909A1 (en) * 2005-01-06 2006-07-13 Pfizer Limited Imidazole derivatives as enzyme reverse transcriptase modulators
US7923465B2 (en) 2005-06-02 2011-04-12 Glenmark Pharmaceuticals S.A. Cannabinoid receptor ligands, pharmaceutical compositions containing them, and process for their preparation
EP1917251B1 (de) 2005-08-21 2013-04-03 Abbott GmbH & Co. KG 5-ring-heteroaromaten-verbindungen und ihre verwendung als bindungspartner für 5-ht5-rezeptoren
CN101511795B (zh) * 2006-07-05 2013-09-18 安万特农业公司 1-芳基-5-烷基吡唑衍生化合物、其制备方法和使用方法
DE602007013573D1 (de) 2006-08-16 2011-05-12 Hoffmann La Roche Nicht-nukleosidische reverse-transkriptase-hemmer
WO2009000663A1 (en) 2007-06-22 2008-12-31 F. Hoffmann-La Roche Ag Urea and carbamate derivatives as non-nucleoside reverse transcriptase inhibitors
AU2008340422B2 (en) 2007-12-21 2014-06-19 F. Hoffmann-La Roche Ag Heterocyclic antiviral compounds
WO2010059529A2 (en) * 2008-11-19 2010-05-27 Merial Limited Compositions comprising an aryl pyrazole and/or a formamidine, methods and uses thereof
US9173728B2 (en) 2008-11-19 2015-11-03 Merial Inc. Multi-cavity container having offset indentures for dispensing fluids
US8748435B2 (en) 2011-04-01 2014-06-10 Novartis Ag Pyrazolo pyrimidine derivatives
CN103588707B (zh) * 2013-06-09 2016-06-01 中国科学院上海有机化学研究所 多氮化合物及其合成方法
JOP20180092A1 (ar) * 2017-10-13 2019-04-13 Gilead Sciences Inc مثبطات hiv بروتياز
WO2019243178A1 (en) * 2018-06-18 2019-12-26 Bayer Aktiengesellschaft Disubstituted 3-pyrazole carboxylates and a process for their preparation via acylation of enolates
EP4717089A3 (de) 2021-08-02 2026-06-24 Syngenta Crop Protection AG Mikrobiozide pyrazolderivate
EP4447682A1 (de) 2021-12-17 2024-10-23 Syngenta Crop Protection AG Mikrobiozide pyrazolderivate
TW202430514A (zh) 2022-09-30 2024-08-01 瑞士商先正達農作物保護股份公司 殺微生物之吡唑衍生物
PY2403614A (es) 2023-01-27 2025-09-11 Syngenta Crop Protection Ag Derivados de pirazol microbiocidas
PY2404467A (es) 2023-02-01 2025-03-31 Syngenta Crop Protection Ag Composiciones fungicidas
PY2447478A (es) 2023-06-14 2025-03-18 Syngenta Crop Protection Ag Composiciones fungicidas
WO2025114167A1 (en) 2023-11-28 2025-06-05 Syngenta Crop Protection Ag Microbiocidal pyrazole derivatives
AR134999A1 (es) 2024-02-02 2026-05-20 Syngenta Crop Protection Ag Derivados de pirazol microbiocidas
WO2025191053A1 (en) 2024-03-14 2025-09-18 Syngenta Crop Protection Ag Microbiocidal pyrazole derivatives
WO2026022173A1 (en) 2024-07-26 2026-01-29 Syngenta Crop Protection Ag Microbiocidal pyrazole compounds

Family Cites Families (141)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3154543A (en) 1961-09-18 1964-10-27 Norwich Pharma Co Preparation of 5-aminofurans
DE1261124B (de) 1961-09-22 1968-02-15 Hoechst Ag Verfahren zur Herstellung von Pyrazolen
US3303200A (en) * 1963-11-05 1967-02-07 American Home Prod Pyrazole-1-ethanol derivatives
JPS5030871A (de) 1973-07-16 1975-03-27
US3960836A (en) 1974-07-22 1976-06-01 Eli Lilly And Company Acylated derivatives of pyrazofurin and process for their preparation
US4041046A (en) 1975-06-06 1977-08-09 American Cyanamid Company 1,2-Dialkyl-3,4,5-trisubstituted pyrazole compounds
SU657745A3 (ru) 1976-06-09 1979-04-15 Санкио Компани Лимитед, (Фирма) Способ получени производных пиразола или их солей или эфиров органических кислот
DE2829289A1 (de) 1978-07-04 1980-01-24 Basf Ag Pyrazolaetherderivate
JPS5533413A (en) 1978-08-29 1980-03-08 Ishihara Sangyo Kaisha Ltd Pyrazole derivative and herbicide containing the same
JPS5535036A (en) 1978-09-04 1980-03-11 Sankyo Co Ltd Herbicidal composition
JPS5535037A (en) 1978-09-04 1980-03-11 Sankyo Co Ltd Herbicidal composition
JPS5535035A (en) 1978-09-04 1980-03-11 Sankyo Co Ltd Herbicidal composition
JPS5535038A (en) 1978-09-04 1980-03-11 Sankyo Co Ltd Weed controlling composition
JPS5535039A (en) 1978-09-04 1980-03-11 Sankyo Co Ltd Weed controlling composition
JPS5547602A (en) 1978-10-25 1980-04-04 Sankyo Co Ltd Herbicide
JPS577403A (en) 1980-06-17 1982-01-14 Ishihara Sangyo Kaisha Ltd Herbicide for paddy field
JPS58185568A (ja) 1982-04-24 1983-10-29 Nissan Chem Ind Ltd ピラゾ−ル誘導体，その製造方法および該誘導体を含有する選択性除草剤
JPS58188858A (ja) 1982-04-27 1983-11-04 Mitsubishi Petrochem Co Ltd 新規ピラゾ−ル誘導体
JPS5988470A (ja) 1982-11-15 1984-05-22 Nippon Nohyaku Co Ltd ピラゾ−ル誘導体及び除草，殺ダニ剤
JPS59104362A (ja) 1982-12-07 1984-06-16 Nissan Chem Ind Ltd ピラゾ−ル誘導体、その製造方法および該誘導体を含有する選択性除草剤
JPS59122472A (ja) 1982-12-29 1984-07-14 Nissan Chem Ind Ltd ピラゾ−ル誘導体、その製造方法および該誘導体を含有する選択性除草剤
JPS59196869A (ja) * 1983-04-22 1984-11-08 Sankyo Co Ltd ピラゾ−ル誘導体及び除草剤
NZ208555A (en) 1983-06-23 1987-06-30 American Cyanamid Co (3-amino-1h-pyrazol-4-yl)-arylmethanone derivatives
JPS608204A (ja) 1983-06-29 1985-01-17 Nissan Chem Ind Ltd 除草組成物
JPS608207A (ja) 1983-06-29 1985-01-17 Nissan Chem Ind Ltd 除草剤組成物
JPS608208A (ja) 1983-06-29 1985-01-17 Nissan Chem Ind Ltd 除草用組成物
JPS6016974A (ja) 1983-07-09 1985-01-28 Nissan Chem Ind Ltd ピラゾ−ル誘導体，その製造方法および選択性除草剤
JPS6034902A (ja) 1983-08-05 1985-02-22 Nissan Chem Ind Ltd 除草性組成物
JPH0680047B2 (ja) 1983-08-24 1994-10-12 日産化学工業株式会社 ピラゾールスルホニルウレア誘導体、その製法および該誘導体を含有する選択性除草剤
JPS6064903A (ja) 1983-09-21 1985-04-13 Nissan Chem Ind Ltd 除草剤組成物
JPS60197605A (ja) 1984-03-19 1985-10-07 Nissan Chem Ind Ltd 除草剤組成物
JPS60202803A (ja) 1984-03-28 1985-10-14 Tokuyama Soda Co Ltd 除草剤組成物
DE3575130D1 (de) 1984-05-12 1990-02-08 Fisons Plc Antiinflammatorische 1,n-diarylpyrazol-3-amine, deren zusammensetzungen und verfahren zu deren herstellung.
JPS6115802A (ja) 1984-06-29 1986-01-23 Nissan Chem Ind Ltd 除草剤組成物
JPS61148105A (ja) 1984-12-21 1986-07-05 Tokuyama Soda Co Ltd 除草剤組成物
US4656260A (en) 1984-12-27 1987-04-07 Kanto Ishi Pharmaceutical Co., Ltd. Cyclic pyrazolo C-nucleoside compound and process for preparing the same
US4744815A (en) 1985-05-11 1988-05-17 Nissan Chemical Industries, Ltd. 4-benzoyl-1-alkyl (alkenyl) - pyrazoles, composition containing them, herbicidal method of using them, and intermediate in their preparation
DE3602728A1 (de) 1985-05-17 1986-11-20 Bayer Ag, 51373 Leverkusen Schaedlingsbekaempfungsmittel auf basis von pyrazolderivaten
DE3520330A1 (de) 1985-06-07 1986-12-11 Bayer Ag, 5090 Leverkusen 5-amino-1-pyridyl-pyrazole
DE3529829A1 (de) 1985-08-21 1987-02-26 Bayer Ag 1-arylpyrazole
JPH0655645B2 (ja) 1985-12-09 1994-07-27 ダイセル化学工業株式会社 除草剤組成物
JPS62145003A (ja) 1985-12-19 1987-06-29 Sumitomo Chem Co Ltd 除草組成物
DE3545036A1 (de) 1985-12-19 1987-09-10 Bayer Ag 5-heterocyclyl-1-aryl-pyrazole
DE3600287A1 (de) 1986-01-08 1987-07-16 Bayer Ag 1-arylpyrazole
DE3603291A1 (de) 1986-02-04 1987-08-06 Bayer Ag 5-amino-1-phenyl-pyrazole
DE3606476A1 (de) 1986-02-28 1987-09-03 Bayer Ag 1-arylpyrazole
DE3617554A1 (de) 1986-05-24 1987-11-26 Bayer Ag 5-oxy(thio)-pyrazol-derivate
JPS6351304A (ja) 1986-08-19 1988-03-04 Nissan Chem Ind Ltd 除草剤組成物
EP0264773A1 (de) 1986-10-16 1988-04-27 American Cyanamid Company 4,5-Dihydro- und 4,5,6,7-Tetrahydropyrazolo[1,5-a]pyrimidine
EP0272704A3 (de) 1986-12-26 1990-11-22 Sanwa Kagaku Kenkyusho Co., Ltd. Verwendung von Pyrazolderivaten zur Behandlung von Immunkrankheiten und Nephropathie
DE3711928A1 (de) 1987-04-09 1988-10-20 Bayer Ag Substituierte 1-arylpyrazole
JPS6413072A (en) 1987-07-07 1989-01-17 Fuji Photo Film Co Ltd Production of 3-alkoxy-5-amino-1h-pyrazoles
US4769907A (en) 1987-07-27 1988-09-13 Northern Telecom Limited Method of making a circuit board pin
DE3724920A1 (de) 1987-07-28 1989-02-09 Bayer Ag Substituierte 1-aryl-5-(het)arylmethylamino-pyrazole
JPH01113304A (ja) 1987-10-28 1989-05-02 Daikin Ind Ltd 除草剤組成物
JPH01211582A (ja) 1988-02-16 1989-08-24 Tanabe Seiyaku Co Ltd ベンゾジオキソール誘導体
JPH01210003A (ja) 1988-02-18 1989-08-23 Daicel Chem Ind Ltd 芳香族ポリスルホン中空糸膜ならびにその製造法
JP2622707B2 (ja) 1988-02-19 1997-06-18 日本カーバイド工業株式会社 アルミ建材の再塗装方法
JPH0296472A (ja) 1988-09-30 1990-04-09 Matsushita Graphic Commun Syst Inc 画像データ縮小方法
GB2224208A (en) 1988-10-20 1990-05-02 Shell Int Research Fungicidal pyrazolyl aryl ketones
JP2694369B2 (ja) 1989-11-27 1997-12-24 京セラ株式会社 窒化珪素質焼結体
US5063245A (en) 1990-03-28 1991-11-05 Nova Pharmaceutical Corporation Corticotropin-releasing factor antagonism compounds
DE4023215A1 (de) 1990-07-21 1992-01-23 Hoechst Ag Substituierte azole, verfahren zu deren herstellung, sie enthaltende mittel und deren verwendung
DE4023488A1 (de) 1990-07-24 1992-01-30 Bayer Ag 1-(pyri(mi)dyl-(2)) -5-hydroxy-pyrazol-mikrobizide
JP2753659B2 (ja) 1990-09-03 1998-05-20 株式会社大塚製薬工場 ピラゾール誘導体
JPH0532662A (ja) 1990-11-09 1993-02-09 Nissan Chem Ind Ltd 置換ピラゾール誘導体および農園芸用殺菌剤
ES2130166T3 (es) 1990-12-31 1999-07-01 Monsanto Co Reduccion de la interaccion de pesticidas en cosechas.
PH30258A (en) 1991-12-30 1997-02-05 Janssen Pharmaceutica Nv Heterocycle-substituted benzenemethanamine derivatives
JPH05262741A (ja) 1992-01-09 1993-10-12 Nissan Chem Ind Ltd フェニルピラゾール誘導体および有害生物防除剤
WO1993015060A1 (fr) 1992-01-22 1993-08-05 Nissan Chemical Industries, Ltd. Derive de pyrazole substitue et bactericide agrohorticole
FR2687675B1 (fr) 1992-01-31 1997-04-18 Roussel Uclaf Nouveaux derives bicycliques de la pyridine, leur procede de preparation, les nouveaux intermediaires obtenus, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant.
AU3497293A (en) 1992-02-26 1993-09-13 F. Hoffmann-La Roche Ag Benzodiazepinones and medicines containing them
GB9207591D0 (en) 1992-04-07 1992-05-20 Glaxo Group Ltd Chemical processes
US5264451A (en) 1992-04-07 1993-11-23 American Home Products Corporation Process for treating hyperglycemia using trifluoromethyl substituted 3H-pyrazol-3-ones
US5274111A (en) 1992-04-07 1993-12-28 American Home Products Corporation Trifluoromethyl substituted 1H-pyrazoles and derivatives thereof
JPH0665237A (ja) 1992-05-07 1994-03-08 Nissan Chem Ind Ltd 置換ピラゾール誘導体および農園芸用殺菌剤
EP0577025A3 (de) 1992-07-01 1998-02-04 Hoechst Aktiengesellschaft Angiotensin-II-Rezeptorantagonisten zur Behandlung und Prophylaxe von koronaren Herzerkrankungen
EP0577023A3 (en) 1992-07-01 1996-12-18 Hoechst Ag Angiotensin-ii receptor-antagonists for the treatment of arrhythmices
JPH0625177A (ja) 1992-07-09 1994-02-01 Nissan Chem Ind Ltd ピラゾール誘導体及び除草剤
US6005109A (en) 1997-10-30 1999-12-21 Pflizer Inc. Pyrazoles and pyrazolopyrimidines having CRF antagonistic activity
KR100190730B1 (ko) 1992-12-17 1999-06-01 디. 제이. 우드, 스피겔 알렌 제이 부신피질 호르몬 유리인자(crf) 길항물질로서 치환된 피라졸
US6103900A (en) 1992-12-17 2000-08-15 Pfizer Inc Pyrazoles and pyrazolopyrimidines having CRF antagonistic activity
TW336932B (en) 1992-12-17 1998-07-21 Pfizer Amino-substituted pyrazoles
DK0674624T3 (da) 1992-12-17 1999-09-13 Pfizer Pyrazoler med CRF-antagonistisk aktivitet
JP3170374B2 (ja) 1993-01-14 2001-05-28 山本化成株式会社 フルオラン化合物及びこの化合物を含有する記録材料
JPH06239864A (ja) 1993-02-15 1994-08-30 Fujisawa Pharmaceut Co Ltd 新規複素環誘導体
WO1994022830A1 (en) 1993-03-31 1994-10-13 Smithkline Beecham Corporation Chemical compounds
DE4333659C2 (de) 1993-10-02 2003-11-06 Guenter Ege 4-Arylmethyl-1H-pyrazol-3-amine, deren Salze und Verfahren zu ihrer Herstellung
JPH07165724A (ja) 1993-12-13 1995-06-27 Nkk Corp ピラゾール誘導体及び血液凝固阻害剤
DE69408950T2 (de) 1993-12-14 1998-10-15 Mitsubishi Chem Corp N-Pyrazolylcarbamatderivate und Fungizide für Landwirtschaft und Gartenbau, die diese als aktive Bestandteile erhalten, Produktion und Zwischenprodukte
JPH07224041A (ja) 1994-02-10 1995-08-22 Mitsubishi Chem Corp ピラゾリル酢酸誘導体およびこれを有効成分とする農園芸用殺菌剤
DE4411235A1 (de) 1994-03-31 1995-10-05 Bayer Ag Thiazolylpyrazolinone
JP3791015B2 (ja) 1994-03-31 2006-06-28 日産化学工業株式会社 スルホンアミド誘導体の製造方法
CA2188809A1 (en) 1994-05-13 1995-11-23 Gee-Hong Kuo Therapeutic phenoxyalkylazoles and phenoxyalkylazines
US5552420A (en) 1994-05-13 1996-09-03 Sterling Winthrop Inc. Therapeutic phenoxyalkylazoles and phenoxyalkylazines
EP0764153A1 (de) 1994-06-06 1997-03-26 Pfizer Inc. Substituierte pyrazole mit "corticotropin-releasing factor"-(crf) antagonistischer aktivität
US5646152A (en) * 1994-06-15 1997-07-08 Pfizer Inc. Methods of administering CRF antagonists
BR9509024A (pt) * 1994-09-26 1997-09-30 Shionogi & Co Derivados de imidazol
AU664686B3 (en) 1994-11-15 1995-11-23 Efisio Theo Pettena A road barrier for a vehicle
US5663199A (en) 1994-11-30 1997-09-02 Uniroyal Chemical Ltd./Ltee Anti-viral aromatic O-alkylated oximes, ethers and thioethers
US5550280A (en) 1994-11-30 1996-08-27 Uniroyal Chemical Ltd./ Uniroyal Chemical Ltee Hindered aromatic ester compounds useful as anti-viral agents
JP3734180B2 (ja) 1994-12-28 2006-01-11 エーザイ株式会社 新規ピラゾール誘導体
JPH08208620A (ja) 1995-02-03 1996-08-13 Takeda Chem Ind Ltd アミノピラゾール誘導体、その製造法および用途
WO1996024589A1 (en) 1995-02-07 1996-08-15 Nissan Chemical Industries, Ltd. Pyrazole derivatives and herbicides
DE19518054A1 (de) 1995-03-08 1996-09-12 Hoechst Schering Agrevo Gmbh N-Arylpyrazolketone und deren Derivate, Verfahren zu ihrer Herstellung, sie enthaltende Mittel und ihre Verwendung als Schädlingsbekämpfungsmittel
IT1281498B1 (it) 1995-06-07 1998-02-18 Sardinian Antiviral Research C Pirazolo - derivati ad attivita' antitumorale, processo per la loro preparazione e composizioni farmaceutiche che li contengono , e
ATE301457T1 (de) 1995-06-12 2005-08-15 Searle & Co Mittel, enthaltend einen cyclooxygenase-2 inhibitor und einen 5-lipoxygenase inhibitor
DE19521822A1 (de) 1995-06-16 1996-12-19 Dresden Arzneimittel Neue, antikonvulsiv wirkende 3-Aminopyrazole, Verfahren zu deren Herstellung und ihre Verwendung
JPH0995482A (ja) 1995-09-29 1997-04-08 Shionogi & Co Ltd α−置換酢酸を有する複素環誘導体、その製造用中間体ならびにそれを含有する農薬
FR2742148B1 (fr) 1995-12-08 1999-10-22 Sanofi Sa Nouveaux derives du pyrazole-3-carboxamide, procede pour leur preparation et compositions pharmaceutiques les contenant
US5684024A (en) 1996-01-25 1997-11-04 Viropharma Incorporated Pyrazole dimers compositions and methods for treating influenza
GB2310207A (en) 1996-02-15 1997-08-20 Pharmacia Spa Antiviral ureido derivatives of substituted heterocyclic compounds
FR2745467A1 (fr) 1996-03-04 1997-09-05 Rhone Poulenc Agrochimie Pyrazoles contre les virus des plantes
US6011052A (en) 1996-04-30 2000-01-04 Warner-Lambert Company Pyrazolone derivatives as MCP-1 antagonists
DE19622189A1 (de) 1996-06-03 1997-12-04 Bayer Ag 3-Cyanaryl-pyrazole
DE19629826A1 (de) 1996-07-24 1998-01-29 Bayer Ag 1,3-Dimethyl-5-fluor-pyrazol-4-carboxamide
GB9625045D0 (en) * 1996-11-30 1997-01-22 Pfizer Ltd Parasiticidal compounds
US6020357A (en) 1996-12-23 2000-02-01 Dupont Pharmaceuticals Company Nitrogen containing heteroaromatics as factor Xa inhibitors
US5907041A (en) 1997-03-12 1999-05-25 Rhone-Poulenc Inc. Process for preparing pyrazole derivatives
CA2289003A1 (en) 1997-05-07 1998-11-12 Basf Aktiengesellschaft Substituted 4-benzoyl-pyrazoles
US5932576A (en) 1997-05-22 1999-08-03 G. D. Searle & Company 3(5)-heteroaryl substituted pyrazoles as p38 kinase inhibitors
US20020156104A1 (en) 1997-06-13 2002-10-24 Jerry L. Adams Novel pyrazole and pyrazoline substituted compounds
JP4123542B2 (ja) 1997-07-07 2008-07-23 住友化学株式会社 ピラゾリノン誘導体の製造法
AU1367599A (en) 1997-11-03 1999-05-24 Boehringer Ingelheim Pharmaceuticals, Inc. Aromatic heterocyclic compounds as anti-inflammatory agents
CA2315720A1 (en) 1997-12-22 1999-07-01 Bayer Corporation Inhibition of p38 kinase activity using substituted heterocyclic ureas
CA2327185A1 (en) 1998-04-08 1999-10-14 Abbott Laboratories Pyrazole inhibitors of cytokine production
PL344004A1 (en) 1998-05-05 2001-09-10 Hoffmann La Roche Pyrazole derivatives as p-38 map kinase inhibitors
WO1999058523A1 (en) 1998-05-14 1999-11-18 G.D. Searle & Co. 1,5-DIARYL SUBSTITUTED PYRAZOLES AS p38 KINASE INHIBITORS
WO1999062513A1 (en) 1998-06-03 1999-12-09 Merck & Co., Inc. Hiv integrase inhibitors
TNSN99111A1 (fr) 1998-06-11 2005-11-10 Pfizer Derives de sulfonylbenzene nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant.
DE19827855A1 (de) 1998-06-23 1999-12-30 Hoechst Schering Agrevo Gmbh Kombinationen aus Herbiziden und Safenern
WO1999067235A1 (en) 1998-06-25 1999-12-29 Sumitomo Pharmaceuticals Co., Ltd. Five-membered ring compounds
DE19829616A1 (de) 1998-07-02 2000-01-05 Bayer Ag Verfahren zur Herstellung von 1-Alkyl-pyrazol-5-carbonsäureestern
DE69935335T2 (de) 1998-08-07 2007-11-22 Novartis Vaccines and Diagnostics, Inc., Emeryville Pyrazole als modulatoren des östrogenrezeptors
JP2000053649A (ja) 1998-08-11 2000-02-22 Sumitomo Pharmaceut Co Ltd スルホニルウレイドピラゾール誘導体
DE19837067A1 (de) 1998-08-17 2000-02-24 Bayer Ag Verfahren zur Herstellung von 1-Alkyl-pyrazol-5-carbonsäureestern
JPH11228312A (ja) 1998-10-16 1999-08-24 Mitsubishi Chemical Corp 水性懸濁状除草剤原液組成物
WO2000066562A1 (en) 1999-05-03 2000-11-09 Dr. Reddy's Research Foundation Pyrazoles having antiinflammatory activity
EP1177188B1 (de) 1999-05-12 2005-10-12 Ortho-McNeil Pharmaceutical, Inc. Pyrazolecarboxamide zur behandlung von fettleibigkeit und anderen erkrankungen
FR2795726A1 (fr) 1999-06-30 2001-01-05 Aventis Cropscience Sa Nouveaux pyrazoles fongicides
CA2315614C (en) * 1999-07-29 2004-11-02 Pfizer Inc. Pyrazoles

Also Published As

Publication number Publication date
BR0112252A (pt) 2003-09-02
PY0116238A (es) 2003-11-03
DE60121590T2 (de) 2006-11-30
US6750230B2 (en) 2004-06-15
ES2266212T3 (es) 2007-03-01
GB0016787D0 (en) 2000-08-30
WO2002004424A1 (en) 2002-01-17
MXPA03000059A (es) 2003-10-15
AU2001267766A1 (en) 2002-01-21
TNSN01102A1 (fr) 2005-11-10
US7141585B2 (en) 2006-11-28
EP1299361B1 (de) 2006-07-19
JP2004502760A (ja) 2004-01-29
UY26819A1 (es) 2002-01-31
US20040209862A1 (en) 2004-10-21
PE20020131A1 (es) 2002-02-21
CA2415492A1 (en) 2002-01-17
DE60121590D1 (en) 2006-08-31
GT200100132A (es) 2002-03-22
SV2002000520A (es) 2002-12-02
US20020032184A1 (en) 2002-03-14
WO2002004424A9 (en) 2002-12-12
PA8521701A1 (es) 2002-08-26
HN2001000146A (es) 2002-01-11
AP2001002204A0 (en) 2001-09-30
EP1299361A1 (de) 2003-04-09

Similar Documents

Publication Publication Date Title
DE60126286D1 (de) Substituierte pyrazole
CY1104912T1 (el) Υποκατεστημενα πυραζολια
IS6662A (is) Imídasól afleiður
NO20025517L (no) Triazolderivater
DK1292604T3 (da) 2-Aminocarbonyl-9H-purinderivater
NO20030473L (no) Imidazolyl-derivater
ATE288437T1 (de) Tetrahydro-heterocycloazepinyl-pyrimidin-deriva e
NO20024766L (no) Etylendiaminderivater
DK1280809T3 (da) Antitumorecteinascidinderivater
ATE298332T1 (de) Decahydro-isochinolinderivate
ATE334114T1 (de) Substituierte c-cyclohexylmethylamin-derivate
ATE335740T1 (de) Ringannelierte pyrazolderivate
AR028602A1 (es) Derivados de pirrol
AR028282A1 (es) Derivados de aminofenil pirimidona
ATE282021T1 (de) Substituierte aminomethyl-phenyl- cyclohexanderivate
DK1322593T3 (da) O-substituerede-6-methyl-tramadol-derivater
ATE280752T1 (de) Aminomethyl-phenyl-cyclohexanonderivate
DE50112454D1 (de) Substituierte 5-amino-1-penten-3-ol-derivate
ATE374776T1 (de) Pyrrolotriazolopyrimidinonderivate
NO20024393D0 (no) 2-fenylpyran-4-on-derivater
DK1246793T3 (da) Substituerede aminomethyl-phenyl-cyclohexanderivater
FI4671U1 (fi) Lamellipyöröhirsi

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties